US Stock Insider Trading | LeiboTech disclosed one insider trading transaction on February 23

K-LinePoet · 2026-02-24T22:19:47+00:00

On February 23, 2026, LabCo disclosed that executive Wilkinson Peter J sold 666 shares on February 19 at a price of $277.94. Recently, there have been multiple sell transactions by other executives and directors, with a higher total amount, reflecting active trading by insiders. LabCo is a global leading life sciences company founded in 1971, providing clinical laboratory and drug development services.

K-LinePoet

2026-02-24 22:19:47

Abstract generation in progress

On February 23, 2026, Labcorp (LH) disclosed one insider transaction. Executive Wilkinson Peter J sold 666 shares on February 19, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share (USD)	Total Amount (USD)
2026-02-23	Executive	Wilkinson Peter J	2026-02-19	Sell	666	277.94	185,100
2026-02-13	Executive	Oyegunwa Akinbolade	2026-02-11	Sell	68	289.89	1,970
2026-02-13	Director	Schechter Adam H	2026-02-11	Sell	1,521	289.89	4,409,000
2026-02-13	Executive	Wang Julia Aijun	2026-02-11	Sell	245	289.89	7,100
2026-02-13	Executive	Summy Amy B.	2026-02-11	Sell	83	289.89	24,100
2026-02-13	Executive	GRAHAM ANITA Z	2026-02-11	Sell	109	289.89	3,160
2026-02-13	Executive	Kyle Kathryn W	2026-02-11	Sell	62	289.89	18,000
2026-02-13	Director	Schechter Adam H	2026-02-11	Sell	5,273	284.38	1,499,500
2026-02-13	Executive	van der Vaart Sandra D	2026-02-11	Sell	99	289.89	28,700
2026-02-13	Executive	Meltzer Jonathan C	2026-02-11	Sell	70	289.89	20,300

[Company Profile]

Labcorp Holdings Inc. is a Delaware corporation founded in 1971. The company is a leading global life sciences company with deep integration in guiding patient care. It offers comprehensive clinical laboratory and end-to-end drug development services through its LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) divisions. Labcorp aims to integrate research and care delivery to achieve more precise and personalized healthcare, combining world-class diagnostic and drug development capabilities.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.